ADAM10 and pancreatic neoplasm: PDACs also showed enhanced expression of c-Myc, suggesting that ADAM10 activation and β-catenin-TCF signaling might be responsible for the increased expression of c-Myc and targeting specific calcium-dependent signaling mechanisms that are altered in PDAC might be a viable strategy for the treatment of pancreatic cancer.